March 13, 2024 - On March 6, 2024, Valisure, an independent quality assurance lab, issued a press release identifying harmfully high levels of benzoyl peroxide in multiple skincare products, specifically products marketed for acne. The press release notes that at high levels, benzoyl peroxide can form into benzene, an established human carcinogen, at concentrations...

March 12, 2024 - On March 8, 2024, the United States FDA expanded approval of Wegovy (semaglutide), making it the first weight loss drug that is FDA-approved for obese and overweight patients at high risk for heart problems. The updated approval allows doctors to prescribe the drug for these patients to reduce the risk of cardiovascular death, heart attack, and...

March 7, 2024 - On Tuesday, March 5, 2024, the NIH issued a release linking semaglutide use with a decreased severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in HIV-positive patients, noting a 31% reduction in liver fat. The study was conducted in Brazil by Advanced Clinical Therapeutics Globally (ACTG) with funding from the National...

March 5, 2024 - On March 4, 2024, Perrigo Company, the manufacturer of Opill, announced that a monthly supply of the hormonal birth control pill costs $19.99 and is now available for pre-order. The product — and its pricing — has been highly anticipated since the United States FDA approved the drug for over-the-counter (OTC) use in July 2023. Beyond...